Autoimmune and autoinflammatory arthritis are often called "invisible illnesses" because many patients may appear healthy on the outside while silently battling chronic pain, fatigue, stiffness, and ...

Arthritis can limit daily activities, but the Aging Untold experts say there are effective ways to manage symptoms and ...

UCB has announced new week 16 results from the phase 3 BE BOLD trial showing that bimekizumab delivered superior joint ...

Osteoarthritis, far from being “simply wear and tear,” demands a multifaceted management strategy, according to a speaker at ...

If youve been diagnosed with psoriatic arthritis, you may have heard the term minimal disease activity (MDA). Broadly speaking, this is the goal of treatment and it means that your disease is well ...

European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...

Whole-body effects: Psoriasis triggers systemic inflammation that can affect organs, joints, and overall energy, not just the skin. Linked conditions: It’s associated with psoriatic arthritis, mental ...

PIP is now worth up to £778 every four-week period for those on the higher rates of the daily living and mobility components.

Bristol Myers Squibb today announced that the European Commission has granted approval to Sotyktu (deucravacitinib), alone or in combination with methotrexate, for the treatment of active psoriatic ...

A 27-year-old woman from Colchester living with psoriatic arthritis has become the face of a national campaign to raise ...

Misconceptions about psoriatic arthritis can make it difficult to diagnose and explain to others.

Please provide your email address to receive an email when new articles are posted on . Ixekizumab plus tirzepatide yielded significant improvement over ixekizumab alone in ACR50 response in patients ...